semaglutide cardiovascular FDA Clears For Cardiac Risk Reduction in Diabetic Patients National Consensus on Semaglutide in

These approaches focus on addressing the likely contributing factors and supporting the body's adjustment to treatment

[DOI] [PubMed] [Google Scholar] Zhang Y., Vanderghinste J., Wang J., Das S

Potential Impact of GLP-1 Receptor Agonists on Erectile Function Existing data point to a positive role of exenatide in facilitating NOdependent smooth muscle relaxation within the corpus cavernosum, likely mediated by reduced NADPH oxidase activity

For a broader overview of side effects across doses, Tirzepatide Side Effects: What to Expect and How to Manage is a useful companion read

The EU5 public healthcare systems also reimburse GLP-1s, but often with prescribing restrictions such as specialist approval or use only as 3rd line treatment at the earliest, which limits penetration